Vaccines and global health: In search of a sustainable model for vaccine development and delivery
Rappuoli R, Black S, Bloom DE
Science translational medicine · 2019-06
Abstract
Most vaccines for diseases in low- and middle-income countries fail to be developed because of weak or absent market incentives. Conquering diseases such as tuberculosis, HIV, malaria, and Ebola, as well as illnesses caused by multidrug-resistant pathogens, requires considerable investment and a new sustainable model of vaccine development involving close collaborations between public and private sectors.
MeSH terms
- Humans
- Neisseria meningitidis, Serogroup A
- Neisseria meningitidis, Serogroup B
- Vaccines
- Ebola Vaccines
- Immunization Schedule
- World Health Organization
- Global Health